Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Mitochondria are dynamic organelles that play a key role in energy conversion. Optimal mitochondrial function is ensured by a quality-control system tightly coupled to fusion and fission. In this connection, mitofusin 2 (Mfn2) participates in mitochondrial fusion and undergoes repression in muscle from obese or type 2 diabetic patients. Here, we provide in vivo evidence that Mfn2 plays an essential role in metabolic homeostasis. Liver-specific ablation of Mfn2 in mice led to numerous metabolic abnormalities, characterized by glucose intolerance and enhanced hepatic gluconeogenesis. Mfn2 deficiency impaired insulin signaling in liver and muscle. Furthermore, Mfn2 deficiency was associated with endoplasmic reticulum stress, enhanced hydrogen peroxide concentration, altered reactive oxygen species handling, and active JNK. Chemical chaperones or the antioxidant N -acetylcysteine ameliorated glucose tolerance and insulin signaling in liver-specific Mfn2 KO mice. This study provides an important description of a unique unexpected role of Mfn2 coordinating mitochondria and endoplasmic reticulum function, leading to modulation of insulin signaling and glucose homeostasis in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Deficiency of Mfn2 in skeletal muscle leads to reduced mitochondrial respiration and increased oxidative stress leading to inhibition of insulin signaling. As a result, high‐fat‐fed Mfn2‐deficient mice show glucose intolerance and greater insulin resistance, which highlights the importance of Mfn2 in the maintenance of normal muscle metabolism (Sebastian et al, 2012).”
From Mfn2 deficiency links age‐related sarcopenia and impaired autophagy to activation of an adaptive mitophagy pathway (2016) · cites this paper as Sebastian et al, 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MFN2 deletion in young muscle causes extensive mitochondrial fragmentation, mitochondrial dysfunction, ROS production, ER stress, and autophagy inhibition resulting in muscle atrophy [67, 186].”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [67]
Experimental — accuracy not yet measuredIn the citing paper
“For instance, MFN2-knockout mice exhibited enhanced hepatic glucose production and impaired response to insulin [67, 68].”
From Mitochondrial Adaptation in Skeletal Muscle: Impact of Obesity, Caloric Restriction, and Dietary Compounds (2024) · cites this paper as [67]
In the citing paper
“Indeed, MFN2 bridges mitochondria to ER/SR, facilitating critical processes linked to ER–mitochondria interactions like calcium homeostasis and the modulation of the UPR during ER stress via PERK [63, 65–68].”
From The connection between the dynamic remodeling of the mitochondrial network and the regulation of muscle mass (2021) · cites this paper as [67]
In the citing paper
“Indeed, deletion of Mfn2 in the liver disrupts mitochondria-ER connectivity and thereby induces ER stress-mediated susceptibility to metabolic disease upon high-fat feeding (Sebastian et al, 2012), indicating once more that the regulation of mitochondrial dynamics is essential to meet metabolic challenges.”
From Mitochondrial response to nutrient availability and its role in metabolic disease (2014) · cites this paper as Sebastian et al, 2012
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844 · cited 1×
“Wild-type or L-KO mice were treated or not treated with TUDCA for 3 wk as reported (31).”
MethodFission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082 · cited 1×
“M morphology, response to apoptotic stimuli, mitochondrial metabolism, and quality control are in part controlled through the balance between mitochondrial fusion and fission (1, 2).”
BackgroundChen, H., Detmer, S. A., Ewald, A. J., Griffin, E. E., Fraser, S. E., & Chan, D. C. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200211046 · Cited by 2,601 · cited 1×
“Alterations in mitochondrial morphology associated with Mfn2 ablation have also been reported in cardiomyocytes (36), Purkinje cells (37), and mouse embryo fibroblasts (38).”
BackgroundSP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
Bennett, B. L., Sasaki, D. T., Murray, B. W., O'Leary, E. C., Sakata, S. T., Xu, W., Leisten, J. C., Motiwala, A., Pierce, S., Satoh, Y., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251194298 · Cited by 2,558 · cited 4×
“Bennett BL, et al. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase.”
MethodInfluentialMitofusin 2 tethers endoplasmic reticulum to mitochondria
de Brito, O. M., & Scorrano, L. (2008) · Nature · doi:10.1038/nature07534 · Cited by 2,442 · cited 4×
“This observation suggests greater calcium storage in the ER of cells lacking Mfn2, a notion that is consistent with data obtained in mouse embryo fibroblasts (8).”
BackgroundResultInfluentialDysfunction of Mitochondria in Human Skeletal Muscle in Type 2 Diabetes
Kelley, D. E., He, J., Menshikova, E. V., & Ritov, V. B. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2944 · Cited by 2,321
Ichijo, H., Nishida, E., Irie, K., Dijke, P. T., Saitoh, M., Moriguchi, T., Takagi, M., Matsumoto, K., Miyazono, K., & Gotoh, Y. (1997) · Science · doi:10.1126/science.275.5296.90 · Cited by 2,307
Impaired Mitochondrial Activity in the Insulin-Resistant Offspring of Patients with Type 2 Diabetes
Petersen, K. F., Dufour, S., Befroy, D., Garcia, R., & Shulman, G. I. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031314 · Cited by 2,193
Mitochondrial dysfunction in the elderly: possible role in insulin resistance
Petersen, K. F., Befroy, D., Dufour, S., Dziura, J., Ariyan, C., Rothman, D. L., DiPietro, L., Cline, G. W., & Shulman, G. I. (2003) · Science · doi:10.1126/science.1082889 · Cited by 2,107
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821 · cited 6×
“Yoon JC, et al. (2001) Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1.”
BackgroundInfluential
Cited by
Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
“Deregulation of mitochondria dynamics with a shift towards fission promotes metabolic dysfunction as demonstrated by the onset of obesity and IR following the ablation of fusion protein in mice [141,142].”
BackgroundMitochondrial Dynamics Controls T Cell Fate through Metabolic Programming
Buck, M. D., O’Sullivan, D., Klein Geltink, R. I., Curtis, J. D., Chang, C.-H., Sanin, D. E., Qiu, J., Kretz, O., Braas, D., van der Windt, G. J. W., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.035 · Cited by 1,443
Mitochondrial Dynamics and Metabolic Regulation
Wai, T., & Langer, T. (2016) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.12.001 · Cited by 1,300
Mitochondrial Dynamics in the Regulation of Nutrient Utilization and Energy Expenditure
Liesa, M., & Shirihai, O. S. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.002 · Cited by 1,341
“This is in part due to an additional site for superoxide formation (ETF-Qo, an exclusive site for electron entry into the ETC through fatty acid beta oxidation) (Seifert et al., 2010).”
BackgroundSelf-citationPINK1-Phosphorylated Mitofusin 2 Is a Parkin Receptor for Culling Damaged Mitochondria
Chen, Y., & Dorn, G. W. (2013) · Science · doi:10.1126/science.1231031 · Cited by 1,323
Mitochondrial Dynamics — Mitochondrial Fission and Fusion in Human Diseases
Archer, S. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1215233 · Cited by 1,102
Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances
Xu, X., Pang, Y., & Fan, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02253-4 · Cited by 800
Insulin resistance: review of the underlying molecular mechanisms
Yaribeygi, H., Farrokhi, F. R., Butler, A. E., & Sahebkar, A. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27603 · Cited by 929
“Oxidative stress plays a prominent role in IR and mitochondria are a major source of free radicals (Rains & Jain, 2011; Sebastian et al., 2012).”
BackgroundYilmaz, B., Terekeci, H., Sandal, S., & Kelestimur, F. (2020) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-019-09521-z · Cited by 748
“Changes in mitochondrial fission and fusion contribute to mitochondrial dysfunction, oxidative stress and β-cell apoptosis that may cause disrupted glucose homeostasis [139, 154].”
BackgroundArruda, A. P., Pers, B. M., Parlakgül, G., Güney, E., Inouye, K., & Hotamisligil, G. S. (2014) · Nature Medicine · doi:10.1038/nm.3735 · Cited by 720
Biochemical and cellular properties of insulin receptor signalling
Haeusler, R. A., McGraw, T. E., & Accili, D. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.89 · Cited by 739
Metabolic control of cell death
Green, D. R., Galluzzi, L., & Kroemer, G. (2014) · Science · doi:10.1126/science.1250256 · Cited by 647
De Felice, F. G., & Ferreira, S. T. (2014) · Diabetes · doi:10.2337/db13-1954 · Cited by 639
“Interestingly, mitochondrial dysfunction and increased ROS generation were recently found to activate JNK and to lead to insulin resistance in skeletal muscle and liver (133).”
BackgroundMitochondrial dynamics in type 2 diabetes: Pathophysiological implications
Rovira-Llopis, S., Bañuls, C., Diaz-Morales, N., Hernandez-Mijares, A., Rocha, M., & Victor, V. M. (2017) · Redox Biology · doi:10.1016/j.redox.2017.01.013 · Cited by 657
“Furthermore, it is important to note that abnormal glucose homeostasis may not always be a cause, but rather a consequence, of altered mitochondrial dynamics, as suggested by several studies [22,23,25].”
BackgroundResultMAM (mitochondria-associated membranes) in mammalian cells: Lipids and beyond
Vance, J. E. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.11.014 · Cited by 625
Imbalanced OPA1 processing and mitochondrial fragmentation cause heart failure in mice
Wai, T., García-Prieto, J., Baker, M. J., Merkwirth, C., Benit, P., Rustin, P., Rupérez, F. J., Barbas, C., Ibañez, B., & Langer, T. (2015) · Science · doi:10.1126/science.aad0116 · Cited by 551
“inmitochondrial ultrastructure anddynamics occur in response to altered metabolic demands (8–11), and components involved inmitochondrial fusion are central regulators of cellularmetabolism (12).”
BackgroundBetz, C., Stracka, D., Prescianotto-Baschong, C., Frieden, M., Demaurex, N., & Hall, M. N. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1302455110 · Cited by 538
“Interestingly, liver-specific KO of Mfn2, a key MAM protein, confers a whole-body phenotype strikingly similar to that of liver-specific rictor KO (12).”
Where is mTOR and what is it doing there?
Betz, C., & Hall, M. N. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201306041 · Cited by 527
Critical reappraisal confirms that Mitofusin 2 is an endoplasmic reticulum–mitochondria tether
Naon, D., Zaninello, M., Giacomello, M., Varanita, T., Grespi, F., Lakshminaranayan, S., Serafini, A., Semenzato, M., Herkenne, S., Hernández-Alvarez, M. I., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606786113 · Cited by 521
“The role of Mfn2 as a tether was confirmed independently in the heart (13), in pro-opiomelanocortin neurons (14), and in the liver (15).”
BackgroundFormation and function of phosphatidylserine and phosphatidylethanolamine in mammalian cells
Vance, J. E., & Tasseva, G. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.08.016 · Cited by 521
Mitofusin 2 in POMC neurons connects ER stress with leptin resistance and energy imbalance
Schneeberger, M., Dietrich, M. O., Sebastián, D., Imbernón, M., Castaño, C., Garcia, A., Esteban, Y., Gonzalez-Franquesa, A., Rodríguez, I. C., Bortolozzi, A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.003 · Cited by 519
Self-citationMitochondrial dysfunction in obesity
de Mello, A. H., Costa, A. B., Engel, J. D. G., & Rezin, G. T. (2018) · Life Sciences · doi:10.1016/j.lfs.2017.11.019 · Cited by 508
Mitofusins, from Mitochondria to Metabolism
Schrepfer, E., & Scorrano, L. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.02.022 · Cited by 495
Raturi, A., & Simmen, T. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.04.013 · Cited by 447
“Moreover, in mammalian cells ER– mitochondria separation also disrupts calcium transfer [77] and causes ER stress [75,132].”
BackgroundThe Mitochondrial Basis of Aging and Age-Related Disorders
Srivastava, S. (2017) · Genes · doi:10.3390/genes8120398 · Cited by 420
“Reduced expression of Mfn1 and/or Mfn2 in skeletal muscle has been linked to obesity and type 2 diabetes mellitus in both rodents and humans [81,89,90].”
BackgroundMfn2 modulates the UPR and mitochondrial function via repression of PERK
Muñoz, J. P., Ivanova, S., Sánchez‐Wandelmer, J., Martínez‐Cristóbal, P., Noguera, E., Sancho, A., Díaz‐Ramos, A., Hernández‐Alvarez, M. I., Sebastián, D., Mauvezin, C., et al. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.168 · Cited by 451
“In this respect, we propose that the alterations detected in tissues upon Mfn2 ablation, such as enhanced ROS production, defective mitochondrial respiration, and deficient insulin signalling and glucose handling (Sebastian et al , 2012), are, at least in part, the result of enhanced PERK activity.”
InfluentialSelf-citationRole of Cardiolipin in Mitochondrial Signaling Pathways
Dudek, J. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00090 · Cited by 428
“…of mitochondria in mouse skeletal muscle, induced by the mutation of genes involved in mitochondrial morphology (see above) was reported to cause severe changes insulin signaling, without interference with the contractile functions (Sebastián et al., 2012; Touvier et al., 2015; Wai et al., 2015).”
BackgroundMitochondrial quality control and muscle mass maintenance.
Romanello, V., & Sandri, M. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2015.00422 · Cited by 434
“Indeed, Mfn2 bridges mitochondria to ER/SR facilitating important processes linked to ER-mitochondria interactions like calcium homeostasis and signaling (de Brito and Scorrano, 2009; Ngoh et al., 2012; Sebastian et al., 2012; Munoz et al., 2013; Ainbinder et al., 2015).”
BackgroundInfluentialDeficient Endoplasmic Reticulum-Mitochondrial Phosphatidylserine Transfer Causes Liver Disease
Hernández-Alvarez, M. I., Sebastián, D., Vives, S., Ivanova, S., Bartoccioni, P., Kakimoto, P., Plana, N., Veiga, S. R., Hernández, V., Vasconcelos, N., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.010 · Cited by 400
“0 J) IP Mfn2 Mfn2 (1-613) (expressed in liver and purified)”
BackgroundInfluentialSelf-citationTubbs, E., Theurey, P., Vial, G., Bendridi, N., Bravard, A., Chauvin, M.-A., Ji-Cao, J., Zoulim, F., Bartosch, B., Ovize, M., et al. (2014) · Diabetes · doi:10.2337/db13-1751 · Cited by 411
“In line with our data, recent studies demonstrated that loss or mutations of MAM proteins could be associated with impaired glucose homeostasis in mice (8,34) and that liver-specific overexpression of a MAM protein, such as Mfn2, is sufficient to improve diet-induced insulin resistance (9).”
BackgroundResultMitochondria-associated membranes (MAMs) and inflammation
Missiroli, S., Patergnani, S., Caroccia, N., Pedriali, G., Perrone, M., Previati, M., Wieckowski, M. R., & Giorgi, C. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0027-2 · Cited by 379
Sebastián, D., Sorianello, E., Segalés, J., Irazoki, A., Ruiz‐Bonilla, V., Sala, D., Planet, E., Berenguer‐Llergo, A., Muñoz, J. P., Sánchez‐Feutrie, M., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201593084 · Cited by 396
Self-citationMitochondrial function in hypoxic ischemic injury and influence of aging
Ham, P. B., & Raju, R. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.06.006 · Cited by 366
Mitofusin 2: from functions to disease
Filadi, R., Pendin, D., & Pizzo, P. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0023-6 · Cited by 356
Determinants and outcomes of mitochondrial dynamics
Quintana-Cabrera, R., & Scorrano, L. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.02.012 · Cited by 347
Mitochondrial fusion/fission dynamics in neurodegeneration and neuronal plasticity
Bertholet, A. M., Delerue, T., Millet, A. M., Moulis, M. F., David, C., Daloyau, M., Arnauné-Pelloquin, L., Davezac, N., Mils, V., Miquel, M. C., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.10.011 · Cited by 363
Mitochondrial Dynamics at the Interface of Immune Cell Metabolism and Function
Rambold, A. S., & Pearce, E. L. (2018) · Trends in Immunology · doi:10.1016/j.it.2017.08.006 · Cited by 341
Liu, Y. J., McIntyre, R. L., Janssens, G. E., & Houtkooper, R. H. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111212 · Cited by 334
“Indeed, liver-specific ablation of Mfn2 rather than Mfn1 in mice evokes ER stress (Kulkarni et al., 2016; Sebastian et al., 2012).”
Sergi, D., Naumovski, N., Heilbronn, L. K., Abeywardena, M., O’Callaghan, N., Lionetti, L., & Luscombe-Marsh, N. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00532 · Cited by 347
Repairing mitochondrial dysfunction in disease
Sorrentino, V., Menzies, K. J., & Auwerx, J. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104908 · Cited by 337
A guide to understanding endoplasmic reticulum stress in metabolic disorders
Lemmer, I. L., Willemsen, N., Hilal, N., & Bartelt, A. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101169 · Cited by 310
“Interestingly, one hallmark of MFN2 loss and disturbed mitochondrial quality control is that this defect does not occur in isolation but rather has a broad impact on organelle dynamics and function, as loss of MFN2 is associated with ER stress and abnormal lipid droplets [14,18].”
BackgroundCerS6-Derived Sphingolipids Interact with Mff and Promote Mitochondrial Fragmentation in Obesity
Hammerschmidt, P., Ostkotte, D., Nolte, H., Gerl, M. J., Jais, A., Brunner, H. L., Sprenger, H.-G., Awazawa, M., Nicholls, H. T., Turpin-Nolan, S. M., et al. (2019) · Cell · doi:10.1016/j.cell.2019.05.008 · Cited by 318
Wu, S., Lu, Q., Wang, Q., Ding, Y., Ma, Z., Mao, X., Huang, K., Xie, Z., & Zou, M.-H. (2017) · Circulation · doi:10.1161/circulationaha.117.030235 · Cited by 320
Mfn2 is critical for brown adipose tissue thermogenic function
Boutant, M., Kulkarni, S. S., Joffraud, M., Ratajczak, J., Valera‐Alberni, M., Combe, R., Zorzano, A., & Cantó, C. (2017) · The EMBO Journal · doi:10.15252/embj.201694914 · Cited by 293
mTOR signaling in cellular and organismal energetics
Albert, V., & Hall, M. N. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.12.001 · Cited by 304
Skeletal muscle mitochondrial remodeling in exercise and diseases
Gan, Z., Fu, T., Kelly, D. P., & Vega, R. B. (2018) · Cell Research · doi:10.1038/s41422-018-0078-7 · Cited by 287
Mitochondrial Dynamics: Coupling Mitochondrial Fitness with Healthy Aging
Sebastián, D., Palacín, M., & Zorzano, A. (2017) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2017.01.003 · Cited by 282
“In the studies relating to obesity and T2DM, it is possible that impaired mitochondrial dynamics contributes to disease pathogenesis and/or progression.”
BackgroundInfluentialSelf-citationThe role of type 2 diabetes in neurodegeneration
Verdile, G., Fuller, S. J., & Martins, R. N. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.04.008 · Cited by 272
Mitochondrial quality control in human health and disease
Liu, B.-H., Xu, C.-Z., Liu, Y., Lu, Z.-L., Fu, T.-L., Li, G.-R., Deng, Y., Luo, G.-Q., Ding, S., Li, N., et al. (2024) · Military Medical Research · doi:10.1186/s40779-024-00536-5 · Cited by 171
Mechanism of increased risk of insulin resistance in aging skeletal muscle
Shou, J., Chen, P.-J., & Xiao, W.-H. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-0523-x · Cited by 283
“Mitochondria are the major site of ROS production [25], and mitochondrial dysfunction will cause an increase in ROS production, and high levels of ROS impair insulin signaling pathways and induce skeletal muscle insulin resistance [18].”
BackgroundSkeletal muscle insulin resistance: role of mitochondria and other ROS sources
Di Meo, S., Iossa, S., & Venditti, P. (2017) · Journal of Endocrinology · doi:10.1530/joe-16-0598 · Cited by 282
“It has also been found that MFN2 deficiency in mouse soleus muscles increases H2O2 concentration, produces mitochondrial dysfunction, activates JNK and blocks insulin-stimulated AKT phosphorylation leading to muscle IR (Sebastián et al. 2012).”
BackgroundWikstrom, J. D., Mahdaviani, K., Liesa, M., Sereda, S. B., Si, Y., Las, G., Twig, G., Petrovic, N., Zingaretti, C., Graham, A., et al. (2014) · The EMBO Journal · doi:10.1002/embj.201385014 · Cited by 262
“To test this prediction, we reduced the rate of mitochondrial fusion by knocking down the pro-fusion protein Mitofusin 2 (Mfn2) using transduction of adenovirus encoding for 5 different microRNAs against Mfn2 or scrambled at the UTR of GFP (Supplementary Fig 6D) (Sebastian et al, 2012).”
MethodInfluentialSelf-citationStructure, function, and regulation of mitofusin‐2 in health and disease
Chandhok, G., Lazarou, M., & Neumann, B. (2018) · Biological Reviews · doi:10.1111/brv.12378 · Cited by 247
“Additionally, Mfn2 deficiency led to increased expression of ER chaperone proteins, resulting in amplified ER stress (Ngoh et al., 2012; Sebastian et al., 2012).”
BackgroundRieusset, J. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0416-1 · Cited by 248
Filadi, R., Theurey, P., & Pizzo, P. (2017) · Cell Calcium · doi:10.1016/j.ceca.2017.01.003 · Cited by 235
Skeletal muscle mitochondria as a target to prevent or treat type 2 diabetes mellitus
Hesselink, M. K. C., Schrauwen-Hinderling, V., & Schrauwen, P. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.104 · Cited by 242
Mitofusin 2 is required to maintain mitochondrial coenzyme Q levels
Mourier, A., Motori, E., Brandt, T., Lagouge, M., Atanassov, I., Galinier, A., Rappl, G., Brodesser, S., Hultenby, K., Dieterich, C., et al. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201411100 · Cited by 231
“Beyond its role in mitochondrial fusion, MFN2 has also been implicated in ER–mitochondria tethering (de Brito and Scorrano, 2008) and in ER stress caused by mitochondrial dysfunction (Sebastián et al., 2012).”
BackgroundLepretti, M., Martucciello, S., Burgos Aceves, M., Putti, R., & Lionetti, L. (2018) · Nutrients · doi:10.3390/nu10030350 · Cited by 232
“Liver specific Mfn2 KO mice have higher levels of mitochondrial fragmentation and glucose intolerance and lower responses to insulin in the liver [49].”
BackgroundKang, J., Hong, J., & Lee, S. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12319 · Cited by 231
“In addition, hepatic deletion of mitofusin 2 increases ROS generation, impairs insulin signaling, and causes glucose tolerance in mice, indicating a beneficial role of mitochondrial fusion process in stress conditions [65].”
BackgroundMitofusins 1 and 2 Are Essential for Postnatal Metabolic Remodeling in Heart
Papanicolaou, K. N., Kikuchi, R., Ngoh, G. A., Coughlan, K. A., Dominguez, I., Stanley, W. C., & Walsh, K. (2012) · Circulation Research · doi:10.1161/circresaha.112.274142 · Cited by 221
“Furthermore, Mfn-2 in skeletal muscle is important in preserving insulin sensitivity and repressing oxidant stress.(28) Regarding the heart, both Mfn-1 and Mfn-2 are shown to be important during early embryonic cardiac development, and in adulthood they protect against long-term cardiac dysfunction.”
BackgroundCausal roles of mitochondrial dynamics in longevity and healthy aging
Sharma, A., Smith, H. J., Yao, P., & Mair, W. B. (2019) · EMBO reports · doi:10.15252/embr.201948395 · Cited by 220
Regulation of muscle protein synthesis and the effects of catabolic states
Gordon, B. S., Kelleher, A. R., & Kimball, S. R. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.05.039 · Cited by 208
“, 2012), and the expression of mitofusin 1 and 2, which promote mitochondrial fusion and maintain metabolic function (Santel et al., 2003; Sebastian et al., 2012), are also significantly decreased during early cachexia (White et al.”
BackgroundMartin, O. J., Lai, L., Soundarapandian, M. M., Leone, T. C., Zorzano, A., Keller, M. P., Attie, A. D., Muoio, D. M., & Kelly, D. P. (2014) · Circulation Research · doi:10.1161/circresaha.114.302562 · Cited by 212
Mitochondria Associated Membranes (MAMs): Architecture and physiopathological role
Barazzuol, L., Giamogante, F., & Calì, T. (2021) · Cell Calcium · doi:10.1016/j.ceca.2020.102343 · Cited by 196
Molina, A. J. A., Bharadwaj, M. S., Van Horn, C., Nicklas, B. J., Lyles, M. F., Eggebeen, J., Haykowsky, M. J., Brubaker, P. H., & Kitzman, D. W. (2016) · JACC: Heart Failure · doi:10.1016/j.jchf.2016.03.011 · Cited by 207
“In mice, genetic ablation of Mfn2 leads to the development of impaired glucose tolerance, hyperinsulinemia, and insulin resistance (44).”
BackgroundOPA1 deficiency promotes secretion of FGF21 from muscle that prevents obesity and insulin resistance
Pereira, R. O., Tadinada, S. M., Zasadny, F. M., Oliveira, K. J., Pires, K. M. P., Olvera, A., Jeffers, J., Souvenir, R., Mcglauflin, R., Seei, A., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201696179 · Cited by 211
“Moreover, insulin resistance might be exacerbated by mutations in or altered expression of mitochondrial dynamics proteins that impair fusion or promote mitochondrial fission (Civitarese et al , 2010; Zorzano et al , 2010; Sebastian et al , 2012).”
Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency
Rodríguez‐Nuevo, A., Díaz‐Ramos, A., Noguera, E., Díaz‐Sáez, F., Duran, X., Muñoz, J. P., Romero, M., Plana, N., Sebastián, D., Tezze, C., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201796553 · Cited by 207
“Mitochondrial metabolism, quality control, response to apoptotic stimuli, and hormone activity are partly controlled through the balance between mitochondrial fusion and fission (Twig et al , 2008; Liesa et al , 2009; Sebastian et al , 2012; Liesa & Shirihai, 2013; Munoz et al , 2013).”
Self-citationMitochondrial function in development and disease
Rossmann, M. P., Dubois, S. M., Agarwal, S., & Zon, L. I. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048912 · Cited by 184
“Furthermore, because Mfn2 ablation triggers ER stress in many systems (Schneeberger et al., 2013; Sebastian et al., 2012), it would be interesting to see whether ER stress inhibitors also influence the transport of calpastatin.”
BackgroundTubbs, E., Chanon, S., Robert, M., Bendridi, N., Bidaux, G., Chauvin, M.-A., Ji-Cao, J., Durand, C., Gauvrit-Ramette, D., Vidal, H., et al. (2018) · Diabetes · doi:10.2337/db17-0316 · Cited by 202
“We next explored whether the reduction of organelle coupling, by reducing GRP75 or MFN2 protein levels by specific siRNA, can alter insulin action in muscle cells as observed previously in hepatocytes (6).”
BackgroundTur, J., Pereira-Lopes, S., Vico, T., Marín, E. A., Muñoz, J. P., Hernández-Alvarez, M., Cardona, P.-J., Zorzano, A., Lloberas, J., & Celada, A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108079 · Cited by 191
“In this regard, Mfn2 is associated with obesity and type 2 diabetes in both humans and rodents (Bach et al., 2005; Sebastián et al., 2012; Zorzano et al., 2015).”
BackgroundSelf-citationSripetchwandee, J., Chattipakorn, N., & Chattipakorn, S. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00496 · Cited by 190
“In the second study, mice with liver-specific ablation of mitofusin-2 (Mfn2) developed glucose intolerance, enhanced hepatic gluconeogenesis as well as impaired insulin signaling in the liver and muscles (54).”
BackgroundRomanello, V., & Sandri, M. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03662-0 · Cited by 197
Dorn, G. W., & Kitsis, R. N. (2015) · Circulation Research · doi:10.1161/circresaha.116.303554 · Cited by 187
Diet impact on mitochondrial bioenergetics and dynamics
Putti, R., Sica, R., Migliaccio, V., & Lionetti, L. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00109 · Cited by 192
“Indeed, Mfn2 deficiency in mice produces mitochondrial dysfunction, increases oxidative stress and endoplasmic reticulum stress and activates JNK impairing insulin signaling in liver and skeletal muscle (Sebastián et al., 2012).”
BackgroundInfluentialStress-responsive regulation of mitochondria through the ER unfolded protein response
Rainbolt, T. K., Saunders, J. M., & Wiseman, R. L. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.06.007 · Cited by 185
Mitochondrial morphology controls fatty acid utilization by changing CPT1 sensitivity to malonyl‐CoA
Ngo, J., Choi, D. W., Stanley, I. A., Stiles, L., Molina, A. J. A., Chen, P., Lako, A., Sung, I. C. H., Goswami, R., Kim, M., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022111901 · Cited by 176
Self-citationMechanisms Orchestrating Mitochondrial Dynamics for Energy Homeostasis
Yu, S. B., & Pekkurnaz, G. (2018) · Journal of Molecular Biology · doi:10.1016/j.jmb.2018.07.027 · Cited by 182
“Liverspecific ablation of Mfn2 causes mitochondrial dysfunction, ER stress, and enhanced generation of reactive oxygen species, which then leads to impaired insulin signaling and glucose intolerance [80].”
BackgroundStructural insights of human mitofusin-2 into mitochondrial fusion and CMT2A onset
Li, Y.-J., Cao, Y.-L., Feng, J.-X., Qi, Y., Meng, S., Yang, J.-F., Zhong, Y.-T., Kang, S., Chen, X., Lan, L., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12912-0 · Cited by 166
Caturano, A., Rocco, M. P., Tagliaferri, G., Piacevole, A., Nilo, D., Lorenzo, G. D., Iadicicco, I., Donnarumma, M., Galiero, R., Acierno, C., et al. (2025) · Antioxidants · doi:10.3390/antiox14010072 · Cited by 209
Durak, A., Olgar, Y., Degirmenci, S., Akkus, E., Tuncay, E., & Turan, B. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0790-0 · Cited by 179
Is Mitochondrial Dysfunction a Common Root of Noncommunicable Chronic Diseases?
Diaz-Vegas, A., Sanchez-Aguilera, P., Krycer, J. R., Morales, P. E., Monsalves-Alvarez, M., Cifuentes, M., Rothermel, B. A., & Lavandero, S. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa005 · Cited by 175
Rieusset, J., Fauconnier, J., Paillard, M., Belaidi, E., Tubbs, E., Chauvin, M.-A., Durand, A., Bravard, A., Teixeira, G., Bartosch, B., et al. (2016) · Diabetologia · doi:10.1007/s00125-015-3829-8 · Cited by 166
The Good and the Bad of Mitochondrial Breakups
Sprenger, H.-G., & Langer, T. (2019) · Trends in Cell Biology · doi:10.1016/j.tcb.2019.08.003 · Cited by 179
At the right distance: ER-mitochondria juxtaposition in cell life and death
Naon, D., & Scorrano, L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.05.011 · Cited by 178
Metabolic implications of organelle–mitochondria communication
Gordaliza‐Alaguero, I., Cantó, C., & Zorzano, A. (2019) · EMBO reports · doi:10.15252/embr.201947928 · Cited by 172
“Furthermore, treatment of liver-specific Mfn2 knockout mice with an ER stress blocker restores insulin sensitivity and glucose homeostasis [166], thereby suggesting that the functional link between MFN2 and the UPR has metabolic relevance.”
InfluentialXia, W., Veeragandham, P., Cao, Y., Xu, Y., Rhyne, T. E., Qian, J., Hung, C.-W., Zhao, P., Jones, Y., Gao, H., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-00978-0 · Cited by 176
“Obesity is associated with hyperinsulinemia and diabetes 11,12 and studies have suggested a link between mitochondrial dysfunction, reduced energy expenditure and insulin resistance 13 .”
BackgroundRole of Mitochondrial Dysfunction in Hypertension and Obesity
Lahera, V., de las Heras, N., López-Farré, A., Manucha, W., & Ferder, L. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0710-9 · Cited by 176
Mitochondrial dynamics in the central regulation of metabolism
Nasrallah, C. M., & Horvath, T. L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.160 · Cited by 166
Sood, A., Jeyaraju, D. V., Prudent, J., Caron, A., Lemieux, P., McBride, H. M., Laplante, M., Tóth, K., & Pellegrini, L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408061111 · Cited by 171
“This result is of critical importance because it hints at a major role of Opa1 proteolysis in metabolic adaptation and connects it to the emerging notion that central regulators of mitochondria mitochondria–ER tethering, like Mfn2, might also be central to this process (12).”
BackgroundResultInfluentialTheurey, P., Tubbs, E., Vial, G., Jacquemetton, J., Bendridi, N., Chauvin, M.-A., Alam, M. R., Le Romancer, M., Vidal, H., & Rieusset, J. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw004 · Cited by 175
“This original finding was in line with previous studies showing that mice with liver-specific invalidation of MAM proteins, such as MFN2 (Sebastian et al., 2012) and mTORC2 (Betz et al., 2013), display hyperglycemia, glucose intolerance and increased neoglucogenesis and also that alteration of…”
ResultInfluentialMitochondria-Associated Membranes Response to Nutrient Availability and Role in Metabolic Diseases
Theurey, P., & Rieusset, J. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.09.002 · Cited by 176
Staying cool in difficult times: Mitochondrial dynamics, quality control and the stress response
Shutt, T. E., & McBride, H. M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.05.024 · Cited by 163
Beaulant, A., Dia, M., Pillot, B., Chauvin, M., Ji-cao, J., Durand, C., Bendridi, N., Chanon, S., Vieille‐Marchiset, A., Silva, C. C. D., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.03.017 · Cited by 163
Gebara, E., Zanoletti, O., Ghosal, S., Grosse, J., Schneider, B. L., Knott, G. W., Astori, S., & Sandi, C. (2020) · Biological Psychiatry · doi:10.1016/j.biopsych.2020.12.003 · Cited by 163
Tipping the metabolic scales towards increased longevity in mammals
Riera, C. E., & Dillin, A. (2015) · Nature Cell Biology · doi:10.1038/ncb3107 · Cited by 153
Wang, L., Liu, X., Nie, J., Zhang, J., Kimball, S. R., Zhang, H., Zhang, W. J., Jefferson, L. S., Cheng, Z., Ji, Q., et al. (2015) · Hepatology · doi:10.1002/hep.27420 · Cited by 150
“MFN2 depletion in liver leads to glucose intolerance and hepatosteatosis.(24) MFN2 deficiency is also a common defect in obesity and type 2 diabetes.”
BackgroundLionetti, L., Mollica, M. P., Donizzetti, I., Gifuni, G., Sica, R., Pignalosa, A., Cavaliere, G., Gaita, M., De Filippo, C., Zorzano, A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092753 · Cited by 144
“The different expression pattern of mitochondrial dynamic proteins when comparing the F and L groups was consistent with the observation that the inhibition of mitochondrial fission ameliorates muscle insulin signalling and systemic insulin sensitivity in obese mice [14] as well as the observation that Mfn2 deficiency…”
BackgroundResultMolecular regulation of mitochondrial dynamics in cardiac disease
Nan, J., Zhu, W. M., Rahman, M. S. U., Liu, M., Li, D. X., Su, S., Zhang, N., Hu, X., Yu, H., Gupta, M. P., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.03.006 · Cited by 160
Mitochondrial response to nutrient availability and its role in metabolic disease
Gao, A. W., Cantó, C., & Houtkooper, R. H. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303782 · Cited by 148
“…of Mfn2 in the liver disrupts mitochondria-ER connectivity and thereby induces ER stress-mediated susceptibility to metabolic disease upon high-fat feeding (Sebastian et al , 2012), indicating once more that the regulation of mitochondrial dynamics is essential to meet metabolic challenges.”
Impaired Mitochondrial Dynamics and Bioenergetics in Diabetic Skeletal Muscle
Liu, R., Jin, P., LiqunYu, Wang, Y., Han, L., Shi, T., & Li, X. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092810 · Cited by 146
“In addition, expression of MFN2 improved HFD-induced insulin resistance and glucose homeostasis in liver [40,41].”
Metadata
- Authors
- Sebastián, D., Hernández-Alvarez, M. I., Segalés, J., Sorianello, E., Muñoz, J. P., Sala, D., Waget, A., Liesa, M., Paz, J. C., Gopalacharyulu, P., Orešič, M., Pich, S., Burcelin, R., Palacín, M., & Zorzano, A.
- Affiliations
- Instituto de Salud Carlos III (ES)
- Institute for Research in Biomedicine (IRB Barcelona), 08028 Barcelona, Spain;
- Inserm (FR)
- VTT Technical Research Centre of Finland (FI)
- Institute for Research in Biomedicine (ES)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2012-03-16
- Volume
- 109
- Issue
- 14
- Pages
- 5523-5528
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3325712
- OpenAlex
- W2006754278
- Cited by
- 673
- References
- 39
- Citations by year
- 2026: 31 · 2025: 41 · 2024: 42 · 2023: 51 · 2022: 56 · 2021: 61 · 2020: 60 · 2019: 47 · 2018: 62 · 2017: 52 · 2016: 47 · 2015: 38 · 2014: 47 · 2013: 30 · 2012: 7
- FWCI
- 15.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- mitofusin 2, mitochondrial fusion, endoplasmic reticulum stress, insulin signaling, glucose homeostasis, hepatic gluconeogenesis, impaired glucose tolerance, reactive oxygen species, hydrogen peroxide, JNK activation, chemical chaperones, N-acetylcysteine, liver-specific knockout mice, type 2 diabetes, mitochondrial quality control
- MeSH terms
- Animals, Endoplasmic Reticulum, Glucose, Homeostasis, Insulin, Insulin Resistance, Liver, Mitochondria, Signal Transduction, Mice, Knockout, Muscle, Skeletal, GTP Phosphohydrolases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.